Skip to content

The individualized red cells transfusion strategy for theperioperative patients: A prospective randomized controlled multi-center clinical trial

The individualized red cells transfusion strategy for the perioperative patients: A prospective randomized controlled multi-center clinical trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-INR-17014085
Enrollment
Unknown
Registered
2017-12-28
Start date
2017-12-31
Completion date
Unknown
Last updated
2018-01-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

red cells transfusion trigger

Interventions

experimental group:the red cells transfusion strategy guided by application of West China Liu's score
control group:the red cells transfusion trigger based on the judgment of physicians according to current transfusion guidelines

Sponsors

Department of Anesthesiology, Third Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, China
Lead Sponsor

Eligibility

Sex/Gender
All
Age
14 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Patients aged bigger than 14 years old; 2. Height of usual place of residence less than 2,500 metres above sea level; 3. Perioperative hemoglobin level possibly less than 10g/dL or preoperative hemoglobin level lower than 10g/dL.

Exclusion criteria

Exclusion criteria: 1. ASA classification V or VI; 2. Severe blood system diseases; 3. The hemoglobin of defective oxygen-carrying capacity; 4. Hypervolemic hemodilution; 5. Patients can not cooperate with the study for any reasons, such as language barriers, mental illness, unable to go to the research centeretc,etc; 6. Patients had taken other test drugs or been involved in other clinical trials within three months prior to the present study; 7. Not suitable for the study, after assessment by the investigators.

Design outcomes

Primary

MeasureTime frame
The proportion of patients who received allogeneic red cells transfusion;The quantity of allogeneic red cells transfusion;mortality rate;rate of severe complication;

Secondary

MeasureTime frame
ICU admission rate and ICU length of stay;Hemoglobin level postoperatively;Healing of surgical incision;Length of hospitalization;Cost of transfusion and hospitalization;

Countries

China

Contacts

Public ContactYanjuan Huang

Department of Anesthesiology, Third Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, China

huangyanjuan66@163.com+86 13878825731

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026